{"id":"NCT01318694","sponsor":"Debiopharm International SA","briefTitle":"Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants","officialTitle":"A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFNα2a and Ribavirin in Hepatitis C Genotype 1 Treatment-naïve Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2011-03-18","resultsPosted":"2016-09-30","lastUpdate":"2016-09-30"},"enrollment":1081,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"Alisporivir","otherNames":["DEB025","ALV"]},{"type":"DRUG","name":"Peginterferon alfa-2a","otherNames":["Pegasys®","PEG"]},{"type":"DRUG","name":"Ribavirin","otherNames":["Copegus®","RBV"]},{"type":"DRUG","name":"ALV Placebo","otherNames":["Placebo"]}],"arms":[{"label":"Treatment Arm A","type":"EXPERIMENTAL"},{"label":"Treatment Arm B","type":"EXPERIMENTAL"},{"label":"Treatment Arm C","type":"EXPERIMENTAL"},{"label":"Treatment Arm D","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the safety and efficacy of alisporivir (ALV; DEB025) triple therapy \\[i.e., when added to peginterferon alfa-2a (PEG) and ribavirin (RBV)\\] to optimize treatment in treatment-naïve participants with hepatitis C virus (HCV) genotype 1 (GT1)","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Sustained Virologic Response (SVR) 12 Weeks After the End of Treatment (SVR12)","timeFrame":"12 weeks after the end of treatment","effectByArm":[{"arm":"Treatment Arm A","deltaMin":68.6,"sd":null},{"arm":"Treatment Arm B","deltaMin":68.9,"sd":null},{"arm":"Treatment Arm C","deltaMin":69.4,"sd":null},{"arm":"Treatment Arm D","deltaMin":52.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":146,"countries":["United States","Argentina","Australia","Belgium","Canada","France","Germany","Hong Kong","Hungary","Italy","Mexico","Poland","Puerto Rico","Romania","Russia","South Korea","Spain","Taiwan","Thailand","United Kingdom","Vietnam"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":273},"commonTop":["Anaemia","Headache","Fatigue","Pyrexia","Neutropenia"]}}